The story floats Samsung and Microsoft as potential buyers, but both seem like long shots.

FORBES: RIM: Jefferies Upgrades, As WebOS Leaves The Field

Meanwhile, as Pfizer had to conduct long safety studies to deal with the lung capacity issue, insulin shots got less painful as companies like Becton, Dickinson developed less painful needles and drug firms started to market insulin in easy-to-use pre-packaged "pen" devices.

FORBES: Pfizer Kills Exubera